Business Context and Reporting Period
This Form 8-K filing by Veracyte, Inc. (VCYT) is dated July 12, 2021. The report discloses a significant executive leadership change within the company's financial management team.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of Rebecca Chambers as Chief Financial Officer (CFO), effective July 19, 2021. Concurrently, Jane Alley will resign as Acting CFO on the same date but will remain as Vice President, Corporate Controller and Principal Accounting Officer.
Compensation and Management Commentary
The Compensation Committee approved a letter agreement for Ms. Chambers with the following terms:
- Base Salary: $450,000 annually.
- Sign-on Bonus: $100,000.
- Annual Bonus: Discretionary up to 55% of base salary.
- Stock Options: 67,000 shares vesting 25% after one year, then monthly over 36 months.
- Restricted Stock Units (RSUs): 34,000 shares vesting 25% on September 2, 2022, then quarterly over 12 quarters.
- Performance RSUs (PSUs): Up to 13,600 shares based on performance metrics for fiscal years ending December 31, 2022, and 2023.
Severance and Change of Control:
- Standard Termination: 50% of base salary plus up to 6 months of COBRA coverage.
- Change of Control Termination: 150% of base salary, 150% of target/actual bonus, up to 18 months of COBRA, and 100% acceleration of unvested equity awards (performance awards deemed achieved at target).
Investor Verification Checklist
- Verify the exact vesting schedules and performance metrics for the PSU awards in the full Letter Agreement.
- Confirm the filing of the Letter Agreement and Change of Control Agreement as exhibits to the upcoming Form 10-Q for the quarter ending September 30, 2021.
- Review Ms. Chambers' prior roles at Outset Medical and Illumina for potential conflicts of interest or non-compete implications.
- Monitor the transition period between July 12 and July 19, 2021, to ensure continuity of financial reporting.